No abstract available
Keywords:
COVID-19; biomarkers; chronic fatigue syndrome; long COVID; neuro-immune; neurodegenerative diseases; neuroinflammation; neuropsychiatric disorders.
Grants and funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The C2F program at Chulalongkorn University in Thailand, grant number 64.310/436/2565 to AA provided funding for the project.